外泌体之家 | 细胞外膜泡领域核心平台—exosomes & microvesicles—小膜泡大作用

 找回密码
 立即注册
查看: 1827|回复: 0
打印 上一主题 下一主题

JCI:肿瘤外泌体(exosome)HSP72介导STAT3依赖的免疫抑制作用

[复制链接]

758

主题

930

帖子

5万

积分

超级版主

Rank: 8Rank: 8

积分
54599
跳转到指定楼层
楼主
发表于 2015-12-14 19:26:16 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
本帖最后由 Johnny 于 2015-12-14 18:00 编辑

J Clin Invest:肿瘤外泌体(exosomeHSP72介导STAT3依赖的免疫抑制作用


版权归属外泌体之家,未经许可,严禁转载,谢谢合作


      骨髓来源的抑制性细胞(Myeloid-derived suppressor cells,MDSCs)是骨髓来源的一群异质性细胞,是树突状细胞(dendritic cells,DCs)、巨噬细胞和(或)粒细胞的前体,具有显著抑制免疫细胞应答的能力。在长有肿瘤的小鼠和人体内这类细胞增多,并促进了肿瘤的生长。
      来自法国国家健康与医学研究院的研究人员们从小鼠细胞系培养上清中分离出肿瘤来源的外泌体(exosome)(tumor-derived exosomes, TDEs),并发现外泌体(exosome)上的HSP72通过激活STAT3抑制了MDSCs的免疫抑制作用。另外,肿瘤来源的可溶性分子通过Erk激发了MDSCs的扩增。外泌体(exosome)HSP72通过TLR2/MyD88依赖的方式诱导IL-6的自分泌,从而激活STAT3。更重要的是,在3个不同的小鼠肿瘤模型中使用dimethyl amilorid抑制外泌体(exosome)的分泌可增强化疗药物cyclophosphamide的抗肿瘤效果。人肿瘤细胞系来源的外泌体(exosome)可激活MDSCs,从而激发其Hsp72/TLR2依赖的免疫抑制作用。用amiloride(一种高血压治疗药物,也可以抑制外泌体(exosome)的形成)处理肿瘤病人来源的MDSCs可降低其免疫抑制作用。
      简言之,该工作发现肿瘤来源的外泌体(exosome)含有膜蛋白HSP72,促进MDSCs的免疫抑制功能,抑制了肿瘤的免疫监督。


Chalmin,F., et al. (2010). "Membrane-associated Hsp72 from tumor-derived exosomes mediatesSTAT3-dependent immunosuppressive function of mouse and human myeloid-derivedsuppressor cells." J Clin Invest 120(2): 457-471. IF=13.2
          Myeloid-derived suppressor cells (MDSCs) have beenidentified in humans and mice as a population of immature myeloid cells withthe ability to suppress T cell activation. They accumulate in tumor-bearingmice and humans and have been shown to contribute to cancer development. Here,we have isolated tumor-derived exosomes (TDEs) from mouse cell lines and shownthat an interaction between TDE-associated Hsp72 and MDSCs determines thesuppressive activity of the MDSCs via activation of Stat3. In addition, tumor-derivedsoluble factors triggered MDSC expansion via activation of Erk. TDE-associatedHsp72 triggered Stat3 activation in MDSCs in a TLR2/MyD88-dependent mannerthrough autocrine production of IL-6. Importantly, decreasing exosomeproduction using dimethyl amiloride enhanced the in vivo antitumor efficacy ofthe chemotherapeutic drug cyclophosphamide in 3 different mouse tumor models.We also demonstrated that this mechanism is relevant in cancer patients, asTDEs from a human tumor cell line activated human MDSCs and triggered theirsuppressive function in an Hsp72/TLR2-dependent manner. Further, MDSCs fromcancer patients treated with amiloride, a drug used to treat high bloodpressure that also inhibits exosome formation, exhibited reduced suppressor functions.Collectively, our findings show in both mice and humans that Hsp72 expressed atthe surface of TDEs restrains tumor immune surveillance by promoting MDSCsuppressive functions.

回复

使用道具 举报

26

主题

398

帖子

3043

积分

版主

Rank: 7Rank: 7Rank: 7

积分
3043
沙发
发表于 2015-12-16 11:00:12 | 只看该作者
exosome上的HSP含量很丰富的,最近好多文章做它们啊
回复 支持 反对

使用道具 举报

758

主题

930

帖子

5万

积分

超级版主

Rank: 8Rank: 8

积分
54599
板凳
 楼主| 发表于 2015-12-16 11:32:35 | 只看该作者
惜名 发表于 2015-12-16 11:00
exosome上的HSP含量很丰富的,最近好多文章做它们啊

是哈~~~
回复 支持 反对

使用道具 举报

关闭

站长推荐上一条 /1 下一条

QQ|Archiver|手机版|外泌体之家 | exosomes & microvesicles  

GMT+8, 2024-9-21 06:25 , Processed in 0.220291 second(s), 25 queries .

Powered by Discuz! X3.3

© 2001-2017 Comsenz Inc.

快速回复 返回顶部 返回列表